L-threo-Ritalinic acid is a stereochemically defined piperidine derivative and a major metabolite of methylphenidate. It serves as a pharmaceutical intermediate in the manufacturing of methylphenidate, featuring both an aromatic ring and an amino acid functional group.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 54631-24-2
Neomycin EP Impurity G
Pharmaceutical impurity reference standard
(6R,7R)-Benzhydryl 3-hydroxy-8-oxo-7-(2-phenylacetamido)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
Cephalosporin intermediate
6-Chloro-4-(2-chlorophenyl)-2-quinazolinecarboxylic Acid
Pharmaceutical impurity intermediate
Aminoacetonitril siran
pharmaceutical intermediate
D-erythro-Ritalinic Acid
research compound
D-threo-Ritalinic Acid
active pharmaceutical ingredient
2-Phenyl-2-(piperidin-2-yl)acetic acid hydrochloride
Pharmaceutical intermediate
Ritalinic acid
pharmaceutical intermediate
(2S)-2-phenyl-2-[(2S)-piperidin-2-yl]acetic acid
INGSNVSERUZOAK-RYUDHWBXSA-N
C1CCN[C@@H](C1)[C@H](C2=CC=CC=C2)C(=O)O